107 related articles for article (PubMed ID: 1997941)
1. Immunocytochemical staining of proliferating cells in endoscopically biopsied tissues of gastric carcinomas with monoclonal antibody Ki-67.
Yonemura Y; Kimura H; Ooyama S; Kamata T; Yamaguchi A; Matsumoto H; Ninomiya I; Miyazaki I
Oncology; 1991; 48(2):162-5. PubMed ID: 1997941
[TBL] [Abstract][Full Text] [Related]
2. Assessment of tumor cell kinetics by monoclonal antibody Ki-67.
Yonemura Y; Ohoyama S; Kimura H; Kamata T; Yamaguchi A; Miyazaki I
Eur Surg Res; 1990; 22(6):365-70. PubMed ID: 2079097
[TBL] [Abstract][Full Text] [Related]
3. Growth fractions in gastric carcinomas determined with monoclonal antibody Ki-67.
Yonemura Y; Ooyama S; Sugiyama K; Ninomiya I; Kamata T; Yamaguchi A; Matsumoto H; Miyazaki I
Cancer; 1990 Mar; 65(5):1130-4. PubMed ID: 2406006
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of Ki-67 and argyrophilic nucleolar organizer region staining for lymph node metastasis in gastric cancer.
Kakeji Y; Korenaga D; Tsujitani S; Haraguchi M; Maehara Y; Sugimachi K
Cancer Res; 1991 Jul; 51(13):3503-6. PubMed ID: 2054789
[TBL] [Abstract][Full Text] [Related]
5. Correlation of p53 expression and proliferative activity in gastric cancer.
Yonemura Y; Fushida S; Tsugawa K; Ninomiya I; Fonseca L; Yamaguchi A; Miyazaki I; Urano T; Shiku H
Anal Cell Pathol; 1993 Sep; 5(5):277-88. PubMed ID: 8105878
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness.
Gasparini G; Pozza F; Meli S; Reitano M; Santini G; Bevilacqua P
Anticancer Res; 1991; 11(6):2015-21. PubMed ID: 1776834
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms.
Goldblum JR; Shannon R; Kaldjian EP; Thiny M; Davenport R; Thompson N; Lloyd RV
Mod Pathol; 1993 Nov; 6(6):663-8. PubMed ID: 7508113
[TBL] [Abstract][Full Text] [Related]
8. Ki-67 expression in gastric cancer. Results from a prospective study with long-term follow-up.
Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C
Rom J Morphol Embryol; 2010; 51(4):655-61. PubMed ID: 21103622
[TBL] [Abstract][Full Text] [Related]
9. Ki-67 antigen expression in relation to clinicopathological variables and prognosis in gastric cancer.
Kikuyama S; Kubota T; Shimizu K; Miyakita M
Oncol Rep; 1998; 5(4):867-70. PubMed ID: 9625834
[TBL] [Abstract][Full Text] [Related]
10. Argyrophilic nucleolar organizer region in endoscopically obtained biopsy tissue: a useful predictor of nodal metastasis and prognosis in carcinoma of the stomach.
Kakeji Y; Maehara Y; Orita H; Emi Y; Ichiyoshi Y; Korenaga D; Sugimachi K
J Am Coll Surg; 1996 Jun; 182(6):482-7. PubMed ID: 8646347
[TBL] [Abstract][Full Text] [Related]
11. Ki-67 antibody labeling index in colorectal carcinoma.
Suzuki H; Matsumoto K; Terabe M
J Clin Gastroenterol; 1992 Dec; 15(4):317-20. PubMed ID: 1294637
[TBL] [Abstract][Full Text] [Related]
12. Proliferative activity in gastric cancer determined with cell cycle-related monoclonal antibodies Ki-67 and p105: analysis by flow cytometry.
Kimura H; Yonemura Y; Miyazaki I
J Surg Oncol; 1992 Nov; 51(3):174-8. PubMed ID: 1359195
[TBL] [Abstract][Full Text] [Related]
13. Relations of proliferative activities of gastric carcinoma cells to lymphatic involvement, venous invasion and prognosis.
Wu YF; Xu HM; Chen JQ
Chin Med J (Engl); 2004 Oct; 117(10):1530-5. PubMed ID: 15498378
[TBL] [Abstract][Full Text] [Related]
14. Ki-67 as a prognostic marker in colorectal cancer but not in gastric cancer.
Oshima CT; Iriya K; Forones NM
Neoplasma; 2005; 52(5):420-4. PubMed ID: 16151588
[TBL] [Abstract][Full Text] [Related]
15. Prediction of lymph node metastasis and prognosis from the assay of the expression of proliferating cell nuclear antigen and DNA ploidy in gastric cancer.
Yonemura Y; Fonseca L; Tsugawa K; Ninomiya I; Matsumoto H; Sugiyama K; Ohoyama S; Fushida S; Kimura H; Miyazaki I
Oncology; 1994; 51(3):251-7. PubMed ID: 7910957
[TBL] [Abstract][Full Text] [Related]
16. Changes in the Ki-67 labeling rates of head and neck squamous cell carcinomas during preoperative radiation therapy.
Ogawa Y; Inomata T; Nishioka A; Maeda T; Seguchi H; Kishimoto S; Saito H; Hirota J; Osaki T
Oncology; 1992; 49(6):450-3. PubMed ID: 1465283
[TBL] [Abstract][Full Text] [Related]
17. Assessment of tumor cell kinetics by immunohistochemistry in carcinoma of breast.
McGurrin JF; Doria MI; Dawson PJ; Karrison T; Stein HO; Franklin WA
Cancer; 1987 May; 59(10):1744-50. PubMed ID: 3548942
[TBL] [Abstract][Full Text] [Related]
18. L-Type amino acid transporter 1 (LAT1) expression in lymph node metastasis of gastric carcinoma: Its correlation with size of metastatic lesion and Ki-67 labeling.
Ichinoe M; Yanagisawa N; Mikami T; Hana K; Nakada N; Endou H; Okayasu I; Murakumo Y
Pathol Res Pract; 2015 Jul; 211(7):533-8. PubMed ID: 25908107
[TBL] [Abstract][Full Text] [Related]
19. [Correlation of DNA ploidy, c-erbB-2 protein tissue status, level of PCNA expression and clinical outcome in gastric carcinomas].
Takamura H; Yonemura Y; Hirono Y; Ninomiya I; Sahara H; Tsugawa K; Matsumoto H; Sugiyama K; Fujimura T; Nishimura G
Gan To Kagaku Ryoho; 1993 Apr; 20(6):788-95. PubMed ID: 8098198
[TBL] [Abstract][Full Text] [Related]
20. Ki-67 labeling index is a more reliable measure of solid tumor proliferative activity than tritiated thymidine labeling.
Deshmukh P; Ramsey L; Garewal HS
Am J Clin Pathol; 1990 Aug; 94(2):192-5. PubMed ID: 2371973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
